Femme et Homme
- | Pays :
- United States
- France
- Germany
- | Organes : -
- | Spécialités : -
Extrait
The primary objective of this observational study is to retrospectively collect current survival data for patients originally included in axitinib A4061012 [NCT00076011] study to estimate the 5-year survival rate in subjects with metastatic renal cancer cell treated with axitinib.
Critère d'inclusion
- Carcinoma, Renal Cell